Last reviewed · How we verify

NCT07055776

Compare the Effectiveness of nVNS and TENS on Pain and Quality of Life in Patients of Migraine

Active, enrolled NA Last updated 9 July 2025
What this trial tests

NA trial testing non-invasive vagus nerve stimulation (nVNS) in Migraine in 72 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
17 March 2025
Primary endpoint
1 September 2025
28 February 2026

Quick facts

Lead sponsorSuperior University
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment72
Start date17 March 2025
Primary completion1 September 2025
Estimated completion28 February 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Superior University

Who can join

Adults 18 to 75, any sex, with Migraine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Migraine is a genetically influenced complex neurological disorder characterized by episodes of moderate-to-severe headaches, typically unilateral and frequently accompanied by nausea and heightened sensitivity to light and sound. The common type of migraine headaches is migraine without aura. Migraine has an approximate prevalence of 14.7%, making it the third most common disease in the world. This study aims to compare the effectiveness of non-invasive vagus nerve stimulation (nVNS) and non-invasive transcutaneous electrical nerve stimulation (TENS) in managing pain and improving quality of life (QOL) in patients with migraine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Migraine

Currently open trials in the same condition.

Other Superior University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07055776.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing